Pyrido` 2, 1-a - isoquinoline derivatives as DPP-IV inhibitors

Details for Australian Patent Application No. 2004251830 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Mattei, Patrizio; Boehringer, Markus; Kuhn, Bernd; Narquizian, Robert

Agent Spruson & Ferguson

Pub. Number AU-B-2004251830

PCT Pub. Number WO2005/000848

Priority 03013404.3 20.06.03 EP

Filing date 11 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 29 October 2009

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000848 Priority application(s): WO2005/000848

29 October 2009 Application Accepted

  Published as AU-B-2004251830

26 November 2009 Corrigenda

  Applications Accepted - Name Index Under the name F. Hoffmann-La Roche AG, Application No. 2004251830, under INID (54) correct the title to read Pyrido[2, 1-A]-isoquinoline derivatives as DPP-IV inhibitors

25 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251838-Blocked polyisocyanates

2004251829-Hexahydropyridoisoqinolines as DPPIV inhibitors